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We examined the association between brain atrophy and vascular brain lesions (i.e., white matter lesions
[WMLs] or brain infarcts), alone or in combination, with decline in memory and executive functioning
over 4 years of follow-up in 448 patients (57  9.5 years) with symptomatic atherosclerotic disease from
the Second Manifestations of ARTerial diseasedMagnetic Resonance SMART-MR study. Automated brain
segmentation was used to quantify volumes of total brain, ventricles, cortical gray matter, and WMLs on
1.5-T magnetic resonance imaging (MRI). Brain infarcts were rated visually. WML volume was associated
with signiﬁcant decline in z score of executive functioning. No independent associations between MRI
measures and memory decline were found. Signiﬁcant declines in z scores of memory performance and
of executive functioning were observed in patients with a combination of severe atrophy (upper quartile)
and most vascular brain lesions (upper quartile) compared with those with minimal atrophy (lowest
quartile) and fewest vascular brain lesions (lowest quartile). Our ﬁndings suggest that in patients with
symptomatic atherosclerotic disease, the combination of brain atrophy and WMLs or brain infarcts ac-
celerates cognitive decline over 4 years.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Vascular disease and vascular risk factors have been associated
with brain magnetic resonance imaging (MRI) abnormalities (e.g.,
brain atrophy, white matter lesions [WMLs], and brain infarcts)
(Geerlings et al., 2010; Ikram et al., 2008). Vascular brain lesions, in
particular WMLs and infarcts, and brain atrophy often coexist
(Appelman et al., 2010). Also, these brain abnormalities have been
associated with cognitive impairment (e.g., memory performance,
executive functioning, and information processing speed) not only
in patients with clinical manifestations of vascular disease (Akisaki
et al., 2006; Geerlings et al., 2009; Manschot et al., 2007) but also
in healthy middle-aged and older populations (Au et al., 2006;
Kramer et al., 2007; Longstreth et al., 2005; Prins et al., 2005).Sciences and Primary Care,
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bination of vascular brain lesions and brain atrophy is particularly
detrimental to cognitive performance, more than the sum of their
separate effects (Muller et al., 2011; van der Flier et al., 2005). Also,
in a prospective population-based study in older adults, it was
found that WMLs and brain atrophy interact to produce cognitive
decline (Godin et al., 2010). This was conﬁrmed in a recently
conducted clinical-based study of patients with WMLs (Jokinen
et al., 2012). Most of these previous studies were conducted in
older populations. Yet, it is still unknown if the combination of
vascular brain lesions and brain atrophy is associated with
cognitive decline in late middle-aged patients and whether the
association is different for multiple cognitive domains depending
on the location of brain atrophy (cortical or subcortical).
The aim of the present study was to assess the association
between brain atrophy and vascular lesions, in particular WMLs
and brain infarcts, alone or in combination, with cognitive decline
over 4 years of follow-up in a large cohort of middle-aged patients
with symptomatic atherosclerotic disease.
M. Kooistra et al. / Neurobiology of Aging 35 (2014) 35e41362. Methods
2.1. SMART-MR study
Data were used from the Second Manifestations of ARTerial
diseasedMagnetic Resonance (SMART-MR) study, a prospective
cohort study aimed to investigate brain changes on MRI in 1309
independently living patients with symptomatic atherosclerotic
disease. Details of the design and participants have been described
elsewhere (Geerlings et al., 2010). In brief, between May 2001 and
December 2005, all patients newly referred to the University
Medical Center Utrecht with manifest coronary artery disease,
cerebrovascular disease, peripheral arterial disease, or an abdom-
inal aortic aneurysm and without MR contraindications were
invited to participate. During a 1-day visit to our medical center,
an MRI of the brain was performed, in addition to a physical ex-
amination, ultrasonography of the carotid arteries, and blood and
urine sampling. Risk factors, medical history, and functioning were
assessed with questionnaires. Neuropsychological assessment was
introduced in the SMART-MR study in January 2003 and was
performed on the same day as the MRI and other investigations.
Neuropsychological testing was performed in 831 patients. Be-
tween January 2006 and May 2009, all participants still alive were
invited for follow-up measurements, including MRI of the brain
and neuropsychological assessment. The SMART-MR study was
approved by the ethics committee of our institution, and written
informed consent was obtained from all participants.
2.2. MRI protocol
MRI investigationswere performed on a 1.5-Twhole-body system
(Gyroscan ACS-NT; Philips Medical Systems, Best, The Netherlands).
The protocol consisted of transversal T1-weighted gradient-echo
(repetition time [TR]/echo time [TE] 235/2 ms), transversal
T2-weighted turbospin-echo (TR/TE2200/11and2200/100ms, turbo
factor 12), ﬂuid-attenuated inversion recovery (FLAIR) (TR/TE/inver-
sion time 6000/100/2000 ms), and transversal IR (TR/TE/inversion
time2900/22/410ms) sequences (ﬁeldof view230230mm,matrix
size 180  256, slice thickness 4 mm, no slice gap 38 slices).
2.3. Brain segmentation
We used the T1-weighted gradient-echo, IR, and FLAIR se-
quences for brain segmentation. The segmentation was done with
k-nearest neighbor classiﬁcation, which is a probabilistic seg-
mentation technique that has been described elsewhere (Anbeek
et al., 2004, 2005). The segmentation program distinguishes
cortical gray matter, white matter, sulcal and ventricular cerebro-
spinal ﬂuid, and WMLs. The automatic segmentation was visually
checked, and a further distinction was made between WML and
infarct volumes by manually assigning the lesion volumes to 1 of
these 2 categories. Total brain volume was calculated by summing
the volumes of gray and white matter and, if present, the volumes
of WMLs and infarcts. All volumes cranial to the foramen magnum
were included. As a result, the total brain volume includes the
cerebrum, brain stem, and cerebellum. Total intracranial volume
(ICV) was calculated by summing the total brain volume and the
volumes of sulcal and ventricular cerebrospinal ﬂuid.
2.4. Brain infarcts and WMLs
At baseline and follow-up, infarcts were rated visually by an
investigator and a neuroradiologist, blinded to clinical character-
istics, and were reevaluated in a consensus meeting. Infarcts were
deﬁned as focal hyperintensities on T2-weighted images of >3 mmin diameter. Hyperintensities that were classiﬁed as infarcts and
were located in the white matter had to be hypointense on
T1-weighted and FLAIR images to distinguish them from WMLs.
Infarcts were classiﬁed as present or absent. WML volumes were
normalized for ICV and natural log transformed.
2.5. Brain volumes
Total brain, cortical gray matter, and ventricular volumes were
expressed relative to ICV. Total brain volume, cortical gray matter
volume, ventricular volume were used as indicators of global brain
atrophy, cortical brain atrophy, and subcortical brain atrophy,
respectively.
2.6. Neuropsychological assessment
At baseline and follow-up, memory and executive functioning
was assessed with neuropsychological tests, sensitive to mild im-
pairments as described earlier (Muller et al., 2011). Composite z
scores for the domains memory and executive functioning were
calculated. The composite score for memory included immediate
and delayed recall and the retention score of the 15-word learning
test (a modiﬁcation of the Rey Auditory Verbal Learning test) (Brand
and Jolles, 1985) and the delayed recall of the Rey-Osterrieth
Complex Figure test (Osterrieth, 1944). The composite score for
executive function included the Visual Elevator test (Robertson
et al., 1996), the Brixton Spatial Anticipation test (Burgess and
Shallice, 1996), and the Verbal Fluency test (letter N for baseline
and letter A for follow-up, 1-minute time frame) (Wilkins et al.,
1987). Composite z scores were computed by converting raw
scores to standardized z scores and averaging them across all sub-
tests per domain. Before calculating z scores, the scores of the Visual
Elevator test and the Brixton Spatial Anticipation test were multi-
plied by 1 so that lower scores represented poorer performance.
The composite z scores at follow-up were calculated by using the
means and standard deviations of the baseline test scores.
2.7. Covariates
Premorbid intellectual functioningwas assessed using the Dutch
version of the National Adult Reading test (DART) (Schmand et al.,
1998). Educational level was divided into 7 categories: graded
from primary school (more or less 6 years of education) to academic
degree (more or less 16 years of education), according to the Dutch
educational system. An overnight fasting venous blood sample was
taken to determine lipid and glucose levels. Height andweight were
measured without shoes and heavy clothing, and body mass index
was calculated (kilogram per square meter). Systolic and diastolic
blood pressure (millimeters of mercury) were measured twice in
supine position with sphygmomanometer and averaged. Diabetes
mellituswas deﬁned as the use of glucose-lowering agents, a known
history of diabetes mellitus, or a fasting plasma glucose level 7.0
mmol/L. Use of antidepressants or benzodiazepines, smokinghabits,
and alcohol intake was assessed with questionnaires. Pack-years of
smoking was calculated, and alcohol intake was categorized into
never, former, and current. Ultrasonography was performed to
measure the intima-media thickness (millimeter) in the left and
right common carotid arteries as ameasure of severity of subclinical
atherosclerosis, represented by the mean value of 6 measurements
(Kanters et al., 1998; Simons et al., 1999).
2.8. Study sample
Of the 831 patients inwhomneuropsychological assessmentwas
performed at baseline, MR segmentation data were not available in
Table 1
Baseline patient characteristics (mean  SD, unless stated otherwise) of the total
study sample (n ¼ 448)
Characteristics Total study sample
(n ¼ 448)
Age (y) 57  9.5
Gender (% male) 80
Level of education (range 1e7)a 4 (2e6)
DART scorea 82 (59e97)
Vascular disease categories
Coronary artery disease (%) 63
Cerebrovascular disease (%) 21
Peripheral arterial disease (%) 18
Abdominal aortic aneurysm (%) 5
Vascular risk factors
BMI (kg/m2) 27  3
Systolic blood pressure (mmHg) 141  20
Diastolic blood pressure (mmHg) 82  10
Pack-years smokinga 20 (0e48)
Alcohol intake (% current) 78
Carotid intima-media thickness (mm) 0.91  0.26
Hyperlipidemia (%) 75
Diabetes mellitus (%) 15
Medication
Antidepressant use (%) 5.4
Benzodiazepine use (%) 4.0
MRI measurements
ICV (mL) 1463  126
Total brain volume (mL) (%ICV  SD) 1162  104 (79  3)
Cortical gray matter volume
(mL) (%ICV  SD)
531  57 (36  3)
Ventricular volume (mL) (%ICV  SD) 29  13 (2.0  0.8)
Total WML volume (mL)a, (%ICV)a 1.3 (0.3e5.8), 0.09 (0.02e0.39)
Total infarcts (yes/no, % yes) 160/342, 24
Percentage of missing values before imputation: level of education (2.5%), DART
score (0.9%), BMI (0.2%), smoking (0.2%), alcohol intake (0.2%), carotid intima media
thickness (1.8%), hyperlipidemia (0.9%), diabetes mellitus (1.1%), cortical gray matter
volume (24.8%), and all other variables (0.0%).
Key: BMI, body mass index; DART, Dutch version of the National Adult Reading test;
ICV, intracranial volume; MRI, magnetic resonance imaging; SD, standard deviation;
WML, white matter lesion.
a Median (10the90th percentile).
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[n¼ 8], andmotion or other artefacts [n¼ 32]). Of the remaining 780
patients, 31 died during follow-up and 460 (61% of survivors)
participated in the follow-upexamination (n¼282 refused andn¼7
were lost to follow-up). Neuropsychological assessment at
follow-up was missing in 12 patients. As a result, the analytical
sample consisted of 448 patients. Compared with the 448 partici-
pants, the 332 patients not included in the present analyses were at
studyentry on average older (mean age [standarddeviation {SD}] 59
[10] vs. 57 [10] years, p ¼ 0.004), more often female (27% vs. 20%,
p¼ 0.02), had higher systolic and diastolic blood pressure levels (148
[24] vs. 141 [20] mmHg, p < 0.001, and 85 [12] vs. 83 [11] mmHg,
p¼ 0.01, respectively), and more often had diabetes (26% vs. 15%).
2.9. Data analysis
Missing data rarely occur completely at random, and a complete
case analyses (deletion of all participants with 1 missing values)
leads to loss of statistical power and to biased results (Donders et al.,
2006; Rubin and Schenker, 1991). We therefore used multiple
imputation (10 datasets) to address missing values in the study
sample of 448 patients, using the statistical programR (aregImpute).
First, baseline characteristics were calculated for the analytical
sample. Second, linear regression analyses were used to investigate
independent associations of measures of brain atrophy (total brain,
cortical gray matter, and ventricular volumes), WML volume, and
presence of brain infarcts at baseline with decline in memory and
executive functioning. z scores of memory and executive func-
tioning at follow-up were entered as the respective dependent
variables, and z scores of memory and executive functioning at
baseline were entered as respective covariates. Analyses were also
adjusted for age, sex, educational level, DART score, and follow-up
time in years (model 1). Further adjustments were made for other
baseline MRI measures (total brain volume, total WML volume,
brain infarcts) (model 2).
To assess the combined associations, we ﬁrst explored whether
the combination of brain atrophy and WML volume or presence of
brain infarcts accelerated cognitive decline, beyond the sum of their
separate effects. Therefore, we added interaction terms between
measures of brain atrophy (total brain, gray matter, and ventricular
volumes) and WML volume or presence of brain infarcts to the
regression model (model 1). Because the effects of brain atrophy
and vascular brain lesions on cognitive decline are expected to lead
to an effect in a similar direction, we did not want to miss any in-
dications for a combined association and therefore chose a liberal
cut-off p value for interaction of p < 0.10. If the regression analyses
indicated a combined association, we performed further analyses
by creating joint exposure categories of measures of vascular le-
sions (highest quartile of WML volume vs. 3 lower quartiles, pres-
ence vs. absence of infarcts) and categories of measures of brain
atrophy (lowest quartile of total brain volume and gray matter
volume vs. 3 highest quartiles and highest quartile of ventricular
volume vs. 3 lowest quartiles). The reference category consisted of
patients with fewest vascular lesions and fewest brain atrophy. The
patients with the most pronounced brain abnormalities were the
category of patients in the upper quartile of WML volume or
presence of infarcts and patients in the quartile with most pro-
nounced brain atrophy (lower quartile of total brain volume and
gray matter volume and upper quartile of ventricular volume).
Analysis of covariance was used to calculate mean change in
cognitive performance among the groups. Additional adjustments
were made for the presence of brain infarcts or WML volume at
baseline (model 2). The previously mentioned associations were
additionally adjusted for brain infarcts at follow-up and also for
cardiovascular risk factors (smoking, alcohol use, body mass index,blood pressure, diabetes, hyperlipidemia) and carotid atheroscle-
rosis. Finally, the associations with memory decline as dependent
variable were additionally adjusted for executive functioning (Parks
et al., 2011).
Datawere analyzed using SPSS version 17.0 (Chicago, IL, USA), by
pooling the 10 imputed datasets.3. Results
Mean (SD) age of the study populationwas 57 (10) years, and the
majorityweremen (80%).Meanbaseline ICVwas 1463 (126)mL, and
mean total brain volume was 1162 (104) mL. Median (10the90th
percentile) total WML volume was 1.3 (0.3e5.8) mL (Table 1).
After a mean (range) of 3.7 (3.0e4.6) years of follow-up, larger
baseline WML volume was associated with a signiﬁcant decline in
executive functioning over time (Table 2). These ﬁndings were in-
dependent of age, sex, education, DART score, and follow-up time.
Further adjustments for total brain volume and brain infarcts at
baseline did not change the effect estimate (B ¼ 0.09; 95%
CI: 0.15, 0.02). Presence of brain infarcts at baseline was associ-
ated with decline in memory performance over time but not with
decline in executive functioning. However, this association was not
independent of WML volume and cardiovascular risk factors
(Table 2). No signiﬁcant associations were found betweenmeasures
of brain atrophy and cognitive decline on either domain (Table 2).
We found indications for combined associations of brain atrophy
and vascular lesions with memory decline, in particular between
Table 2
Association of baseline brain volumes and vascular brain lesions with decline in memory performance and executive functioning
Model Memory decline (z score) Executive functioning decline (z score)
B 95% CI B 95% CI
Measures of brain atrophy (% ICV)
Total brain volume, per SD decrease 1 0.06 0.14, 0.01 0.05 0.13, 0.02
2 0.05 0.12, 0.02 0.05 0.12, 0.03
Cortical gray matter volume, per SD decrease 1 0.02 0.05, 0.09 0.01 0.08, 0.06
2 0.03 0.04, 0.10 0.01 0.07, 0.08
Ventricular volume, per SD increase 1 0.05 0.12, 0.01 0.04 0.10, 0.03
2 0.04 0.10, 0.03 0.03 0.09, 0.04
Measures of vascular brain lesions
WML volumea (% ICV), per SD increase 1 0.05 0.11, 0.02 0.09b 0.15, 0.03
2 0.03 0.10, 0.03 0.09b 0.15, 0.03
Infarcts, yes/no 1 0.14b 0.28, 0.00 0.00 0.15, 0.14
2 0.11 0.25, 0.03 0.05 0.10, 0.19
B (95% CI) represents the change in z score for cognitive functioning at follow-up per SD decrease of total brain volume (SD ¼ 2.52%), decrease in gray matter volume (SD ¼
3.32%), increase in ventricular volume (SD ¼ 0.82%), and increase in WML volume (SD ¼ 1.10%) and the change for presence (yes/no) infarcts. Model 1 is adjusted for sex, age,
educational level, DART score, baseline cognition z score, and follow-up time in years, and model 2 is additionally adjusted for baseline measures of either WML volume (not if
WML volume was independent variable) or total brain volume (not if total brain, gray matter, or ventricular volume was independent variable) and for the presence of brain
infarcts at baseline (not if infarcts were independent variable).
Key: BMI, body mass index; CI, conﬁdence interval; DART, Dutch version of the National Adult Reading test; ICV, intracranial volume; SD, standard deviation; WML, white
matter lesion.
a Log-transformed WML.
b p < 0.05.
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volume and graymatter volume (p interaction¼ 0.07), and presence
of infarcts and total brain volume (p interaction ¼ 0.06). Trends for
combined associations were observed for the interaction between
WML volume and ventricular volume (p interaction ¼ 0.10) and
presence of infarcts and graymatter volume (p¼ 0.11). Patientswith
most pronounced brain abnormalities (lower quartile of total brain
or gray matter volume or upper quartile of ventricular volume in
combination with upper quartile of WML volume or presence of
brain infarcts) showed a signiﬁcant decline inmemory performance
comparedwith the reference category. Thosewith either small total
brain or graymatter volume, large ventricular volume, or largeWML
volume or presence of brain infarcts did not show a decline in
memory performance (Fig. 1). Compared with the reference cate-
gory, the mean difference (95% CI) in z score of memory decline
was 0.38 (0.59, 0.17) for patients with large WML volume and
small total brain volume; 0.23 (0.43, 0.02) for patients with
large WML volume and small gray matter volume; 0.18 (0.38,
0.02) for patients with large WML volume and large ventricular
volume; 0.29 (0.50, 0.07) for patients with brain infarcts and
small total brain volume; and0.29 (0.53,0.06) for patientswith
brain infarcts and small gray matter volume.
We found indications for combined associations of brain vol-
ume and WML volume or presence of brain infarcts with decline
in executive functioning, in particular between WML volume and
total brain volume (p interaction ¼ 0.09) and between WML
volume and ventricular volume (p interaction ¼ 0.08). There were
no indications for combined associations of gray matter volume
and WML volume or presence of infarcts or indications for
combined associations of total brain or ventricular volume and
presence of infarcts (p > 0.10). Patients with small total brain
volume or large ventricular volume in combination with large
WML volume showed a signiﬁcant decline in executive func-
tioning compared with the reference category, whereas those
with small total brain volume, large ventricular volume, or large
WML volume did not show such a decline (Fig. 2). Compared with
the reference category, the mean difference (95% CI) in z score of
executive functioning was 0.27 (0.48, 0.06) for patients with
large WML volume and small total brain volume and 0.26
(0.49, 0.06) for patients with large WML volume and large
ventricular volume.Additional adjustment for other MRI measures at baseline, car-
diovascular risk factors, use of antidepressants or benzodiazepines,
brain infarcts at follow-up, and executive functioning (in the as-
sociations with memory decline) only slightly attenuated the effect
estimates (data not shown). Finally, after the use of multiple
imputation to accommodate the missing values, the results
remained essentially the same.
4. Discussion
In this prospective cohort study of late middle-aged patients
with symptomatic atherosclerotic disease, we observed that the
combination of brain atrophy and vascular brain lesions increased
the likelihood of cognitive decline beyond the sum of their separate
effects. For memory decline, cortical brain atrophy interacted with
WML volume or presence of brain infarcts, whereas for executive
functioning decline, this was primarily driven by the combination
of subcortical atrophy and WML volume.
Considering the independent associations between brain im-
agingmeasures and cognitive decline,WMLvolumewas associated
with a decline in executive functioning, but not with memory
decline, which is in line with the literature (Kramer et al., 2007;
Prins et al., 2005). However, whereas associations between mea-
sures of brain atrophy and memory decline have previously been
reported (Kramer et al., 2007), these were not observed in our
present study or in other previous studies (Prins et al., 2005). The
observed associations between measures of brain atrophy and
memory decline that have been reported in previous studies were
mainly found for hippocampal atrophy (Kramer et al., 2007) and
medial temporal lobe atrophy (Rusinek et al., 2003). Because we
had no data of hippocampal or medial temporal lobe atrophy at
baseline, we were not able to examine this. Furthermore, whereas
we did not ﬁnd a signiﬁcant association betweenmeasures of brain
atrophy and decline in executive functioning, others did (Kramer
et al., 2007; Prins et al., 2005). A possible reason for this discrep-
ancy in ﬁnding could be that our study included late middle-aged
participants with relatively intact cognition and relatively few
brain abnormalities.
The combination of brain atrophy and vascular lesions was
related to accelerated decline in memory and executive func-
tioning. Few previous studies addressed this interaction of brain
Fig. 1. Mean changes in memory performance during 4 years of follow-up according to the combination of WML volume and TBV (A), WML volume and GMV (B), WML volume and
VV (C), presence of infarcts and TBV (D), or presence of infarcts and GMV (E). Analyses are adjusted for age, sex, educational level, Dutch version of the National Adult Reading test
score, z score baseline memory performance, and follow-up time. All brain volumes are expressed relative to intracranial volume. Abbreviations: abs., absent; GMV, gray matter
volume; pres., present; TBV, total brain volume; VV, ventricular volume; WML, white matter lesion; *, signiﬁcantly different from reference category (p < 0.05).
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Fig. 2. Mean changes in executive functioning during 4 years of follow-up according to the combination of WML volume and TBV (A), or WML volume and VV (B). Analyses are
adjusted for age, sex, educational level, Dutch version of the National Adult Reading test score, z score baseline executive functioning, and follow-up time. All brain volumes are
expressed relative to intracranial volume. Abbreviations: TBV, total brain volume; VV, ventricular volume; WML, white matter lesion; *, signiﬁcantly different from reference
category (p < 0.05).
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these focused on patientswith Alzheimer’s disease (AD) (Brickman
et al., 2008; van der Flier et al., 2004) and suggested that brain at-
rophyand vascular brain lesions interact in the clinical syndrome of
AD. Patients with large WML volume and large medial temporal
lobe atrophy were found to have the highest risk for AD (van der
Flier et al., 2004). Also, AD patients with a combination of large
brain atrophy and large WML volume showed the steepest rate of
cognitive decline (Brickman et al., 2008). A neuropathological
study has suggested that vascular brain lesions reduce the
threshold for AD pathology (Snowdon et al., 1997). Furthermore, in
ahospital-based prospective cohort studyof patientswithdifferent
degrees of WMLs, signiﬁcant interactions were observed between
WMLs and brain atrophy on cognitive functioning at baseline and
follow-up (Jokinen et al., 2012). This effect was observed for global
cognition and executive functioning but not for memory perfor-
mance.Over time, the interaction of global brain atrophyandWMLs
was only present for global cognition. Finally, interactions between
WMLs and hippocampal atrophy with general cognitive func-
tioning were found in a population-based cohort study of nonin-
stitutionalized older individuals (Godin et al., 2010). In the present
study, we extend previous observations by providing an evaluation
of the domains memory and executive functioning in a younger
study population of patients with symptomatic atherosclerotic
disease. In this patient group where the majority had normal
cognitive functioning, the observed single and combined associa-
tions of brain atrophy and vascular brain lesions on cognitive
decline were subtle. Nevertheless, we show that single brain ab-
normalities (i.e., measures of brain atrophy or vascular lesions)
have limited effect on cognitive decline over 4 years, whereas the
combination of brain atrophy measures and WMLs or infarcts has
signiﬁcant, although perhaps, modest effect on cognitive decline.
Subcortical brain atrophy in combinationwith vascular lesionswas
related to decline in executive functioning, whereas cortical brain
atrophy in combinationwith vascular lesionswas related to decline
in memory performance.
Strengths of this study are the prospective design and the
large number of patients investigated. The volumetric assessment
of brain atrophy and WMLs made it possible to investigate theassociations on a continuous scale, without loss of information
because of categorization of data. This enabled us to more accu-
rately measure WMLs and total brain volume estimates that were
less inﬂuenced by observer bias than visual rating methods. As in
many other follow-up studies of aging, loss to follow-up was a
limitation of the study. However, because patients with better
clinical perspectives will stay in the study, the possible selective
loss to follow-up will have caused an underestimation of the
effects. Furthermore, we did not have longitudinal measures of
information processing speed or global cognitive performance,
although decline on these domains has previously been associ-
ated with brain atrophy and vascular lesions (Jokinen et al., 2012;
Prins et al., 2005). The majority of patients in this study were
men. A possible explanation is that the far majority of patients
with manifest arterial disease are men, at least when the study
started (i.e., 10 years ago). Men have a higher risk to develop
vascular disease compared with women (Barrett-Conner, 1997).
In summary,we observed that in latemiddle-aged patientswith
symptomatic atherosclerotic disease, the combination of brain at-
rophy and WMLs or presence of infarcts accelerates cognitive
decline over 4 years, in a relative cognitive domain-speciﬁc
manner. These ﬁndings provide further evidence for a combined
involvement of brain atrophy and vascular lesions in the etiology of
cognitive decline, already in relatively young patients with symp-
tomatic atherosclerotic disease.
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